
The National Institute of Cholera & Enteric Disease (NICED) in Kolkata, operating under the Indian Council of Medical Research (ICMR), is set to join phase-III clinical trials for India's first dengue vaccine. The need for a preventive vaccine is evident as West Bengal grapples with dengue outbreaks, with over 10,000 cases and 20 deaths reported this year. The vaccine, developed by Panacea Biotech in collaboration with ICMR, targets the DEN 3 strain of the dengue virus prevalent in the region. NICED is the sole trial site in eastern India, with recruitment of volunteers expected to start by November-December.
Like
Save
Share